Physician

George M. Baylor, MD

According to 2025 Medicare claims, George Baylor, MD (NPI: 1093806192) practices interventional pain management (ipm) in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is BLUE RIDGE PAIN MANAGEMENT ASSOCIATES, PC (NPI: 1518118330; TIN: 510579359) and primary practice location at 24016-4701.

Baylor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,395 traditional Medicare patients, billed 31,884 HCPCS/CPT codes, and received $681,228 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 5,003 prescription claims across 1,054 beneficiaries totaling $415,825 in drug costs, led by Qutenza (Capsaicin/Skin Cleanser). 2016 DME data shows 22 claims. Open Payments data shows 95 records totaling $3,294. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	985	9,125	$405,470
2016	1,099	10,094	$396,179
2017	1,172	10,567	$399,951
2018	1,148	9,391	$382,751
2019	1,562	8,500	$513,494
2020	1,315	7,610	$452,644
2021	1,166	10,097	$416,107
2022	1,074	11,639	$356,743
2023	907	15,984	$377,453
2024	1,395	31,884	$681,228

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	796	4,903	$462,222
2016	918	5,186	$455,805
2017	1,009	5,329	$518,390
2018	1,006	4,489	$461,439
2019	1,095	5,678	$526,300
2020	993	5,790	$580,097
2021	1,034	4,639	$445,113
2022	953	3,930	$359,820
2023	1,020	4,630	$408,957
2024	1,054	5,003	$415,825

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$2,188
2016	N/R	22	$2,273
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	234	323	$150
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	665	864	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	596	1,093	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	252	527	$63
80307	Testing for presence of drug, by chemistry analyzers	1,082	1,494	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Qutenza	Capsaicin/Skin Cleanser	16	1,410	$58,088
Botox	Onabotulinumtoxina	35	3,150	$42,020
Oxycodone Hcl	Oxycodone Hcl	1,206	34,652	$33,144
Xtampza Er	Oxycodone Myristate	48	1,439	$30,634
Belbuca	Buprenorphine Hcl	35	1,050	$27,891

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$3,294	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for George M. Baylor, MD?

Tedicare shows public-source Medicare data for George M. Baylor, MD (NPI 1093806192), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George M. Baylor, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George M. Baylor, MD?

George M. Baylor, MD is linked to BLUE RIDGE PAIN MANAGEMENT ASSOCIATES, PC (billing NPI 1518118330) in the available physician profile data.

Does George M. Baylor, MD have Open Payments data?

George M. Baylor, MD has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.